United States · 
Who invested in OncoImmune?
OncoImmune's investors include 3E Bioventures.
United States · Series A startup
Who invested in OncoImmune
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2017, from 1 source
- Latest round
- Series A, $15MJan 2017
- Investors
- 1
The rounds
- Jan 2017
Founders and team
From the SEC filings it signed: 3 on the team.
- Martin DevenportExecutive Officeri
- Pan ZhengExecutive Officeri
- Yang LiuExecutive Officer, Directori
On the board, as filediGary FangerKaren LiuKun-Liang GuanMiao Hong
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about OncoImmune
How much has OncoImmune raised?
OncoImmune has raised $15M across 1 round since 2017.
When did OncoImmune last raise?
OncoImmune's most recent round was a Series A of $15M in Jan 2017.
What was OncoImmune's biggest round?
Its most recent round, $15M in Jan 2017, is also its largest on record.
Who backed OncoImmune first?
OncoImmune's first round on record, in Jan 2017, was backed by 3E Bioventures.
What stage is OncoImmune at?
OncoImmune's latest named round is a Series A, in Jan 2017.
Where is OncoImmune based?
OncoImmune is based in the United States.
Companies like OncoImmune
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.